Galecto, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
GLTO on Nasdaq
Industry
Pharmaceutical Preparations
Location
75 State Street, Suite 100, Boston, MA

Insiders trading volume in the past year

Galecto, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Orbimed Advisors Llc 10%+ Owner $1.13M Aug 15, 2023
Jonathan Freve Chief Financial Officer $75K Jan 3, 2024
Hans T. Schambye Chief Executive Officer, Director $23K -$7.51K -24.6% Jan 3, 2025
Garrett Winslow General Counsel $20.7K -$2.64K -11.3% Jan 3, 2025
Lori Firmani Interim CFO $10.9K -$1.47K -11.9% Jan 3, 2025
Carl Goldfischer Director Jun 20, 2024
Anne Prener Director Jun 20, 2024
Chau Q. Khuong Director Jun 14, 2023
Anders Pedersen Chief Operating Officer Jan 4, 2023
Bertil Lindmark Chief Medical Officer Jan 4, 2023
Stephanie Oestreich Chief Business Officer Jan 4, 2023
David Shapiro Director Jun 20, 2024
Matthew Kronmiller EVP Strategy and CBO Jan 3, 2025
Amy B. Wechsler Director Oct 11, 2024
Jayson Donald Alexander Dallas Director Jun 20, 2024
Amit Munshi Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Galecto, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.